Number of Shares
28,620.00
Current Holdings Value*
$7.73 Mil
% of Portfolio
3.92%
Total Estimate Gain
$5.42 Mil
% of Total Estimate Gain
50.95%

Vanguard Baillie Gifford Global Positive Impact Stock Fund's Alnylam Pharmaceuticals Inc Holding Summary

As of 2025-03-31, VANGUARD VALLEY FORGE FUNDS held 28,620.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $7.73 Mil. This investment constitutes 3.92% of their stock portfolio, and VANGUARD VALLEY FORGE FUNDS now holds 0.02% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.

The initial trade took place in 2022Q3. And since then Vanguard Baillie Gifford Global Positive Impact Stock Fund has made 5 purchases of ALNY, at an average price of $193.30, for a total of 55,023.00 shares. In addition, there have been 4 sales at an average price of $255.09 for 26,403.00 shares. Based on historical transaction data and ALNY's current price of $325.64, Vanguard Baillie Gifford Global Positive Impact Stock Fund's estimated gain on his ALNY holdings is $5.42 Mil, reflecting a 50.95% gain to date.

Vanguard Baillie Gifford Global Positive Impact Stock Fund ALNY ($325.64) Holding Chart

Vanguard Baillie Gifford Global Positive Impact Stock Fund ALNY ($325.64) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1